AFT PHARMACEUTICALS LIMITED 8 September 2020
Results of 2020 Annual Shareholder Meeting
At AFT Pharmaceuticals Limited's (NZX: AFT / ASX: AFP) annual shareholder meeting held virtually today, shareholders were asked to vote on two resolutions, both of which were supported by the Board.
As required by NZX Listing Rule 6.1, all voting was conducted by a poll.
The resolutions passed by shareholders were:
1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year.
2.
That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited.
Detail of the total number of votes cast in person or by a proxy holder are:
Resolution | For | Against | Abstain |
1. That the directors are authorised to fix the fees and expenses of Deloitte as auditor for the 2021 financial year. | 87,540,520 99.99% | 11,972 0.01% | 2,000 |
2. That Ms Marree Atkinson be re-elected as a director of AFT Pharmaceuticals Limited. | 87,552,227 100.00% | 1,145 0.00% | 120 |
Authority for this announcement | |
Name of person authorised to make this announcement | Malcolm Tubby, Chief Financial Officer |
Contact person for this announcement | Malcolm Tubby |
Contact phone number | +64 9 488 0232 |
Contact email address | Investor.relations@aftpharm.com |
Date of release through MAP | 8 September 2020 |
Page 1 of 1
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
AFT Pharmaceuticals Limited published this content on 08 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 September 2020 04:29:03 UTC
